Task: Answer the multiple choice question.
Query: Which drug exhibits a -21.540% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a Nc1ccc(SC(F)(F)F)cc1C(=O)c1ccccc1
b COc1ccccc1N(C(=O)c1snc(C(N)=O)c1N)C(C(=O)NCCC(C)C)c1ccco1
c CC(=O)Nc1ccc2c(CSc3nncs3)cc(=O)oc2c1
Answer: c. CC(=O)Nc1ccc2c(CSc3nncs3)cc(=O)oc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)Nc1ccc2c(CSc3nncs3)cc(=O)oc2c1
CC(=O)Nc1ccc2c(CSc3nncs3)cc(=O)oc2c1
N-[2-oxo-4-(1,3,4-thiadiazol-2-ylsulfanylmethyl)chromen-7-yl]acetamide